Heart rate recovery, cardiac rehabilitation, and erectile dysfunction in males with ischemic heart disease ( Author`s Reply)

Kaynakça (1)

1. Kalka D, Domagala Z, Rusiecki L, Karpinski L, Gebala J, Koleda P, et al. Heart rate recovery, cardiac rehabilitation and erectile dysfunc-tion in males with ischaemic heart disease. Anatol J Cardiol 2016; 16: 256-63 2. Brixius K, Middeke M, Lichtenthal A, Jahn E, Schwinger RH. Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men. Clin Exp Pharmacol Physiol 2007; 34: 327-31. 3. Van de Water A, Janssens W, Van NJ, Xhonneux R, De CJ, Ver-haegen H, Reneman RS, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J Cardiovasc Pharmacol 1988; 11: 552-63. 4. Munzel T, Gori T. Nebivolol: the somewhat-different beta-adrener-gic receptor blocker. J Am Coll Cardiol 2009; 54: 1491-9. 5. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179-84. 6. Aldemir M, Keleş I, Karalar M, Tecer E, Adalı F, Pektaş MB, et al. Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft. Anatol J Cardiol 2016; 16: 131-6.